Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

The osmotic release oral system (OROS) methylphenidate formulation is a prolonged-release medication for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. We conducted a seven-week open-label extension of a double-blind study to assess the safety...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Buitelaar, Jan K, Ramos-Quiroga, J Antoni, Casas, Miguel, Kooij, J J Sandra, Niemelä, Asko, Konofal, Eric, Dejonckheere, Joachim, Challis, Bradford H, Medori, Rossella
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2009
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747385/
https://ncbi.nlm.nih.gov/pubmed/19777067
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki